ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2752

Risk of Hospitalizations for Venous Thromboembolism Among Patients with Selected Systemic Vasculitides: A Nationwide Analysis

Yiming Luo1, Jiehui Xu2, Yumeng Wen1, Alvaro Ramos-Rodriguez1, Changchuan Jiang1, Shuyang Fang1, Mustafa Kagalwalla1 and Neha Ohri3, 1Department of Medicine, Mount Sinai St Luke's and Mount Sinai West Hospitals, Icahn School of Medicine at Mount Sinai, New York, NY, 2Department of Biostatistics, Mailman School of Public Health, Columbia University Medical Center, New York, NY, 3Division of Rheumatology, Department of Medicine, Mount Sinai St Luke's and Mount Sinai West Hospitals, Icahn School of Medicine at Mount Sinai, New York, NY

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: thrombosis and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Vasculitis Poster III: Other Vasculitis Syndromes

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Venous thromboembolism (VTE) contributes significantly to in-hospital morbidity and mortality. Previous studies have suggested that certain vasculitides, including granulomatosis with polyangiitis (GPA) and giant cell arteritis (GCA) are associated with increased risk of VTE. However, there is mixed evidence in the literature about the risk of VTE in patients with polyarteritis nodosa (PAN) and Takayasu’s arteritis (TA). Some of these studies were limited by not adjusting for common cofounders, in this case VTE risk factors. We sought to explore the association of VTE as primary reason for hospitalization in patients with GPA, GCA, PAN and TA using a national inpatient database.

Methods:

We conducted a retrospective cross-sectional study using the National Inpatient Sample (NIS) database for the year 2014. Diagnoses were identified using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. Patients with a principal admission diagnosis of VTE and a secondary diagnosis of GPA, GCA, PAN and TA were included in the study. There were no exclusion criteria. Univariate and multivariate logistic regression models were used to adjust for potential confounders.
In this study, we adjusted for age, gender, race, length of stay and selected common risk factors for VTE such as active smoking, cancer, heart failure, stroke, sepsis, thrombophilia, obesity, nephrotic syndrome, inflammatory bowel disease, pregnancy, postpartum and long bone fracture.

Results:

A total of 287,790 hospitalizations with a principal diagnosis of VTE were identified. Among this cohort, the number of hospitalizations with a secondary diagnosis of GPA, GCA, PAN and TA were 11,285, 16,480, 4,450 and 1,350, respectively. The unadjusted OR for a principal diagnosis of VTE and a secondary diagnosis of any of these four vasculitis reached statistical significance for GPA (OR 2.76, 95% CI 2.10 – 3.64, p < 0.001), GCA (OR 2.45, 95% CI 1.91 – 3.13, P < 0.001), PAN (OR 1.81, 95% CI 1.04 – 3.13, p = 0.035). There was no difference for TA (OR 2.30, 95% CI 0.95 – 5.56, p = 0.065). When adjusting for confounding variables, there was statistical significance for GPA (OR 2.54, 95% CI 1.90 – 3.40, p < 0.001), GCA (OR 1.53, 95% CI 1.18 – 1.98, p = 0.001) and TA (OR 2.46, 95% CI 1.01 – 5.97, p = 0.047), though not for PAN (OR 1.47, 95% CI 0.83 – 2.60, p = 0.183).

Conclusion:

Our study suggests that GPA and GCA are independently associated with increased risk of hospitalizations for VTE, which is consistent with previously published studies in the literature. We found that PAN is associated with increased risk of VTE hospitalizations but is not considered an independent risk factor, which confers a possible explanation for the conflicting results in previous investigations. TA was associated with an increased risk of VTE after adjusting for confounders. Further studies are needed to clarify these relationships further.


Disclosure: Y. Luo, None; J. Xu, None; Y. Wen, None; A. Ramos-Rodriguez, None; C. Jiang, None; S. Fang, None; M. Kagalwalla, None; N. Ohri, None.

To cite this abstract in AMA style:

Luo Y, Xu J, Wen Y, Ramos-Rodriguez A, Jiang C, Fang S, Kagalwalla M, Ohri N. Risk of Hospitalizations for Venous Thromboembolism Among Patients with Selected Systemic Vasculitides: A Nationwide Analysis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/risk-of-hospitalizations-for-venous-thromboembolism-among-patients-with-selected-systemic-vasculitides-a-nationwide-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-of-hospitalizations-for-venous-thromboembolism-among-patients-with-selected-systemic-vasculitides-a-nationwide-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology